About Medical Database
Medical Database provides reliable and updated medical information to healthcare providers, insurance companies, and educational institutions. Our content, written by medical and pharmacy professionals, comprises a range of medical databases to assist healthcare providers in making appropriate clinical decisions, meeting medical necessity, and maintaining compliance.
Our mission is to assist healthcare professionals and organizations in providing the best care to patients by offering reliable, accurate, and insightful medical information in an accessible and professional manner—resulting in better patient outcomes at a reduced cost.
Medical Database strives to be an industry-leading provider of medical information for the healthcare and pharmaceutical industries.
Medical Database offers medical evidence and knowledge-based content through its two laboratory decision system products; LDS® and LDS® Analytics.
LDS is a Testing Management and Utilization platform which identifies the most medically relevant tests. Learn more...
LDS Analytics is an enterprise analytics platform that profiles and benchmarks lab orders and remittance by physicians, practices and labs. Learn more...
Our management team
Our management team is the cornerstone of our company’s success. With diversified professional backgrounds and recognized long-term experience in medical and laboratory industry management, they provide exceptional knowledge, skills and dedication in serving and supporting our clients as well as in guiding our company to be at the forefront of innovation in the healthcare industry.
Safedin Sajo Beqaj, PhD, HCLD (ABB)
Founder, President & CEO
Dr. Sajo Beqaj is board certified in molecular pathology and genetics and licensed as a Bioanalyst and High Complexity Laboratory Director. He has been practicing as a laboratory director since 2005. Read more...
Doctor Beqaj, served as a technical director and was part of the initial management team for several well-known laboratories in clinical lab industry including PathGroup, Nashville, TN; DCL Medical Laboratories, Indianapolis, IN, and Pathology, Inc, Torrance, CA. He is currently serving as off-side CLIA laboratory director for BioCorp Clinical Laboratory, Whittier, CA and Health360 Labs, Garden Grove, CA.
Dr. Baqaj received his Ph.D. in Pathology from Wayne State University Medical School, Detroit, Michigan. He performed his post-doctoral fellowship at Abbott Laboratories from 2001-2003 and with Children’s hospital and Northwestern University from 2003-2005.
Dr. Beqaj has taught in several academic institutions and has published numerous medical textbook chapters and journal articles. He has served as a principal investigator in clinical trials for several well-known pharmaceutical and diagnostic companies and has presented various scientific clinical abstracts and presentations.
He is a member of several medical and scientific associations including the Association of Molecular Pathology, American Association of Clinical Chemistry and the Pan Am Society for Clinical Virology. He has served on a number of clinical laboratory regulatory and scientific committees and has assisted several laboratories and physicians as a Clinical Laboratory Consultant.
Chief Operating Officer, Regulatory and Legal Advisor
Helene Pretsky is a consummate corporate/securities attorney with an expertise in intellectual property who has spent her entire 31-year legal career on representing start-up and growth- oriented companies based on some form of IP, with a focus on companies in the healthcare industry. Read more...
She specializes in overall business strategies for early-stage companies coupled with three decades of experience in private placements, mergers, acquisitions and joint ventures; intellectual property licensing and acquisition agreements, co-development agreements, international and domestic distribution and sales agreements. She began her career in the bio-med/bio-tech industries in San Diego, CA in 1987 at Brobeck, Phleger & Harrison, one of the oldest and most prestigious California law firms, where she specialized in structuring and raising funding for early-stage companies in the pharmaceuticals industry.
An entrepreneur at heart, Ms. Pretsky eventually applied her vast experience in building IP businesses to co-founding and holding top management positions at several start-up companies, both public and private. She received her JD from UCLA School of Law where she was a member of its Law Review. She was the Steering Committee for IDEAS Los Angeles, a new tech conference sponsored by Tel Aviv University which focused on innovations in the healthcare industry.
Timothy Hamill, MD
Chief Medical officer and Medical Advisor
Tim served as the Vice Chair and Director of Laboratory Medicine at UCSF for over 25 years, and he is committed to using his experience for the advancement of the MDB lab decision system. Read more...
Tim is a member of numerous UCSF Medical Center committees and professional societies. Currently, he is the chair of the UCSF Medical Center Point of Care Testing Committee. He is also a member of the California Department of Health Services Clinical Laboratory Technology Advisory Committee (CLTAC), American Society of Hematology, Academy of Clinical Laboratory Physicians and Scientists, and California Society of Pathologists. In addition, Tim is a fellow of the American Society of Clinical Pathologists and College of American Pathologists.
Craig Shimasaki, PhD, MBA
Dr. Shimasaki is co-founder and CEO of Moleculera labs, a neuroimmunology diagnostic laboratory focused on neuropsychiatric and behavioral disorders triggered by autoimmune response, based upon licensed research at the University of Oklahoma Health Sciences Center. He has over 35 years of biotechnology industry experience, starting his career at Genentech. His research and development work included epitope mapping for an HIV vaccine, SNP-based genetic breast cancer risk prediction biomarkers, a rapid influenza diagnostic, and therapeutic and biologic products for infectious and neuropsychiatric diseases. He co-founded nine companies and led five clinical diagnostic tests through FDA 510(k) approval and is a co-inventor on several patents. He was involved in raising over $30 million for these companies and participated in taking five companies public in the U.S. and Canadian stock markets. Read more...
Dr. Shimasaki received his BS in Biochemistry from University of California at Davis, his PhD in Molecular Biology from the University of Tulsa, and his MBA from Northwestern University, Kellogg School of Business. He an Adjunct Professor and Entrepreneur-in-Residence at the University of Oklahoma, Price School of Business and teaches biotechnology entrepreneurship. Dr. Shimasaki has authored and edited two books “The Business of Bioscience: What Goes Into Making a Biotechnology Product” and “Biotechnology Entrepreneurship: Starting, Managing and Leading Biotech Companies.” His passion is to help translate scientific and medical discoveries into acutely needed products so that more patients can live healthier lives.
Rojeet Shrestha, MT, MS, Ph.D., FAACC
Dr. Shrestha has been practicing clinical laboratory medicine since 2005. He is graduated in Medical Laboratory Sciences (2005) and completed his post-graduate training in Clinical Chemistry (2010) from Institute of Medicine, TU Teaching Hospital. He received his Ph.D. in Clinical Biochemistry from Faculty of Health Sciences, Hokkaido University. He is a fellow of AACC Academy, formerly known as the National Academy of Clinical Biochemistry (NACB).Read more...
Currently, Dr. Shrestha is an assistant professor in the Department of Medical Laboratory Sciences, Faculty of Health Sciences, Hokkaido University. He has extensive experience in developing lipid testing and biomarkers for risk stratification of cardiovascular diseases. Dr. Shrestha has published more than 40 medical journal articles, and over a dozen presentations in various international conferences of clinical chemistry and Laboratory Medicine.
He served as secretary of Lipid and Vascular Disease Division of American Association for Clinical Chemistry (AACC) from 2016-2017 and currently serving as an Education Officer for the division. He is an executive member of the Committee for Internet and eLearning (C-IeL) and eAcademy Coordinator of International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). He also serves in executive board of Communication and Publication Division (CPD) and Education and Laboratory Management Committee (ELM) of Asia-Pacific Federation of Clinical Biochemistry and Laboratory Medicine (APFCB).